ING Group’s BioNTech BNTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$209K Buy
+2,126
New +$206K ﹤0.01% 521
2023
Q3
– Sell
-430
Closed -$46.4K – 637
2023
Q2
$46.4K Sell
430
-76
-15% -$8.55K ﹤0.01% 507
2023
Q1
$63K Buy
+506
New +$69.5K ﹤0.01% 569
2022
Q1
– Sell
-2,052
Closed -$529K – 534
2021
Q4
$529K Buy
+2,052
New +$562K ﹤0.01% 593

Other funds holding BNTX

ING Group's BNTX Position: Q3 2026 in Review

ING Group opened a new position in BioNTech (BNTX) in Q3 2026: 2,126 shares worth $209K. The stake represents ﹤0.01% of the portfolio and ranks #521 among its holdings. This is a return to the name: ING Group previously reported a position in BNTX as recently as Q2 2023.

ING Group first reported a position in BNTX in Q4 2021 and has held it in 4 quarters since. The position peaked at $529K in Q4 2021. 223 funds tracked by Wall St. Rank hold BNTX as of Q3 2026.

  • ING Group held 2,126 shares of BioNTech worth $209K as of Q3 2026.
  • BioNTech was a new ING Group position in Q3 2026.
  • BioNTech made up ﹤0.01% of ING Group's portfolio in Q3 2026, its #521 holding.
  • ING Group first reported a position in BioNTech in Q4 2021 and has held it in 4 quarters since.
  • ING Group's BioNTech position peaked at $529K in Q4 2021.
  • 223 funds tracked by Wall St. Rank held BioNTech as of Q3 2026.

Based on ING Group's 13F filing for Q3 2026, filed 10 Nov 2026.